Arginine N-Methyltransferase Inhibitor-1, also known as AMI-1, is an inhibitor of protein arginine methyltransferases (PRMTs). PRMTs are a class of epigenetic modified enzymes that are overexpressed in some cancers, responsible for key functions in tumor development. It has shown antiproliferative effects in both mouse sarcoma 180 and human osteosarcoma U2OS cells. It inhibits gastric cancer, possibly through the downregulation of eukaryotic translation initiation factor 4E and the targeting of type II PRMT5.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































